Haemonetics | HAE - Assets


Haemonetics reported $2.49B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Avanos Medical USD 1.07B 6M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Cerus USD 215.18M 2.11M Sep/2025
Cooper Companies USD 12.42B 29.4M Dec/2025
Fresenius EUR 42.46B 1.14B Sep/2025
Fresenius Medical Care EUR 31B 115.33M Dec/2025
Globus Medical USD 5.3B 207.12M Dec/2025
Haemonetics USD 2.49B 48.73M Dec/2025
Hologic USD 9.18B 165.8M Dec/2025
ICU Medical USD 4.05B 52.39M Dec/2025
Intuitive Surgical USD 20.46B 1.11B Dec/2025
Masimo USD 1.7B 118.6M Dec/2025
Medtronic USD 91.48B 139M Dec/2025
Merit Medical Systems USD 2.69B 54.92M Dec/2025
Neogen USD 3.36B 18.21M Sep/2025
OraSure Technologies USD 403.17M 19.93M Dec/2025
Plus Therapeutics USD 16.32M 2.34M Dec/2025
Quidel USD 5.77B 94.2M Dec/2025
ResMed USD 8.5B 195.02M Dec/2025
STAAR Surgical USD 451.68M 4.68M Dec/2025
Steris USD 10.59B 180.7M Dec/2025
Stryker USD 47.84B 787M Dec/2025
Surmodics USD 169.82M 8.74M Jun/2025
Teleflex USD 6.95B 924.7M Dec/2025
Terumo JPY 2.26T 362.12B Dec/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
US Physical Therapy USD 1.2B 7.74M Dec/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025